Kaleido BioSciences Stock
Kaleido BioSciences is a company working to design and analyze the microbiome system and provide adaptive solutions.
Sign up today and learn more about Kaleido BioSciences Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Kaleido BioSciences Stock
Tremendous new therapeutic opportunities are emerging from our rapidly expanding knowledge of the human microbiome. Kaleido is exploring this newfound territory through a unique discovery platform that develops novel chemistries targeted at specific microbiome functions. Our approach has produced clinically supported leads in multiple disease areas.
Funding History
| August 2015 | $4.5M |
|---|---|
| September 2017 | $60.0M |
| June 2018 | $101M |
Press
The Boston Globe - Jun, 25 2018
Bedford Startup Kaleido Biosciences Raises $101 Million in Funding RoundBusiness Wire - Mar, 26 2018
Kaleido Biosciences Announces Appointments to Leadership TeamEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
